Perfluorohexane-loaded macrophages as a novel ultrasound contrast agent: a feasibility study
- PMID: 18536974
- DOI: 10.1007/s11307-008-0146-3
Perfluorohexane-loaded macrophages as a novel ultrasound contrast agent: a feasibility study
Abstract
Purpose: We investigated in vitro the potential of macrophages to act as targeted vehicle for ultrasound molecular imaging.
Procedures: Murine bone marrow-derived macrophages (BMM), incubated for 3 h with different concentrations of perfluorohexane (PFH) emulsions, were monitored by microscopy, flow cytometry, and ultrasound. Effects of PFH loading on BMM adhesion molecule (PSGL-1, VLA-4, Mac-1, LFA-1) expression were analyzed by flow cytometry. Static adhesion of PFH loaded BMM to unstimulated and TNF-alpha stimulated b.End5 endothelial cells was assessed by microscopy.
Results: Incubation of BMM with PFH emulsions resulted in dose-dependent uptake and increased echogenicity (max. 17 dB). Flow cytometry analyses revealed no down-regulation related to PFH loading of BMM adhesion molecule expression. Endothelial adhesion remained functional, even after 24 h, although PFH loading dose-dependently attenuated static adhesion.
Conclusion: PFH loaded BMM may potentially serve as ultrasound contrast agent for noninvasive detection of atherogenic hotspots in arteries.
Similar articles
-
Echogenic perfluorohexane-loaded macrophages adhere in vivo to activated vascular endothelium in mice, an explorative study.Cardiovasc Ultrasound. 2015 Jan 8;13:1. doi: 10.1186/1476-7120-13-1. Cardiovasc Ultrasound. 2015. PMID: 25567641 Free PMC article.
-
Ultrasonic Perfluorohexane-Loaded Monocyte Imaging: Toward a Minimally Invasive Technique for Selective Detection of Liver Inflammation in Fatty Liver Disease.J Ultrasound Med. 2018 Apr;37(4):921-933. doi: 10.1002/jum.14432. Epub 2017 Oct 9. J Ultrasound Med. 2018. PMID: 28990215
-
Perfluorohexane Emulsions Induce Macrophage-Stimulating Effects through iNOS Expression.ACS Appl Bio Mater. 2025 May 19;8(5):4046-4054. doi: 10.1021/acsabm.5c00191. Epub 2025 Apr 11. ACS Appl Bio Mater. 2025. PMID: 40215334
-
Evaluation of the Theranostic Potential of Perfluorohexane-Based Acoustic Nanodroplets.Biol Pharm Bull. 2019 Dec 1;42(12):2038-2044. doi: 10.1248/bpb.b19-00525. Epub 2019 Sep 25. Biol Pharm Bull. 2019. PMID: 31554747
-
Echogenicity enhancement by end-fluorinated polylactide perfluorohexane nanocapsules: Towards ultrasound-activable nanosystems.Acta Biomater. 2017 Dec;64:313-322. doi: 10.1016/j.actbio.2017.10.002. Epub 2017 Oct 3. Acta Biomater. 2017. PMID: 28986300
Cited by
-
From Micro- to Nano-Multifunctional Theranostic Platform: Effective Ultrasound Imaging Is Not Just a Matter of Scale.Mol Imaging. 2018 Jan-Dec;17:1536012118778216. doi: 10.1177/1536012118778216. Mol Imaging. 2018. PMID: 30213222 Free PMC article. Review.
-
Echogenic perfluorohexane-loaded macrophages adhere in vivo to activated vascular endothelium in mice, an explorative study.Cardiovasc Ultrasound. 2015 Jan 8;13:1. doi: 10.1186/1476-7120-13-1. Cardiovasc Ultrasound. 2015. PMID: 25567641 Free PMC article.
-
Liquid perfluorocarbons as contrast agents for ultrasonography and (19)F-MRI.Pharm Res. 2010 Jan;27(1):1-16. doi: 10.1007/s11095-009-0001-5. Epub 2009 Nov 10. Pharm Res. 2010. PMID: 19902338 Review.
-
Phase-change contrast agents for imaging and therapy.Curr Pharm Des. 2012;18(15):2152-65. doi: 10.2174/138161212800099883. Curr Pharm Des. 2012. PMID: 22352770 Free PMC article. Review.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Research Materials
Miscellaneous